California Legislature (healthcare bills) · February 2, 2026 · Primary source
CA SB 548: California Overdose Death and Addiction Reduction Act of 2025.
Summary
California SB 548, the California Overdose Death and Addiction Reduction Act of 2025, would have required the California Health and Human Services Agency to direct its Behavioral Health Task Force to develop recommendations aimed at reducing alcohol- and drug-related addiction deaths by 50 percent by January 1, 2033. The bill was returned to the Secretary of the Senate pursuant to Joint Rule 56, meaning it did not advance and carries no current legal effect. It did not create new provider obligations or modify existing SUD treatment regulations.
What this may mean
Because the bill was returned to the Secretary of the Senate under Joint Rule 56 and did not become law, it imposes no obligations on providers, payors, or SUD treatment facilities. The bill's proposed reporting and planning framework, including agency adoption of task force recommendations and a 2033 legislative report, does not take effect. SUD treatment providers and behavioral health agencies in California face no new compliance requirements from this measure.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- Federal Register: DEA Diversion Decisions · June 9, 2026Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted TreatmentScore 100
- Kentucky Legislature (healthcare bills) · May 22, 2026KY HB 153: AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.Score 90
- California Medicaid Fraud Control Unit · May 4, 2026Attorney General Bonta Announces $7.4 Billion Purdue Pharma and Sackler Family Opioid Settlement Now in EffectScore 90
- FDA Press Announcements · June 16, 2026FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid OverdoseScore 86
- California Legislature (healthcare bills) · October 20, 2026CA SB 530: Medi-Cal: time and distance standards.Score 83
- New York Legislature (healthcare bills) · September 24, 2026NY S 7984: Relates to exemptions from the recipient restriction programScore 80